Literature DB >> 850067

The role of an activatable esterase in immune-dependent phagocytosis by human neutrophils.

R A Musson, E L Becker.   

Abstract

Diisopropylphosphofluridate, cyclohexyl alkylphosphonofluoridates, and cyclohexyl phenylalkylphosphonofluoridates, which are potent, irreversible inactivators of serine esterases, inhibit the phagocytosis of opsonized sheep erythrocytes by human neutrophils. Two types of inhibition were observed: a) 'cell-dependent' inhibition, which is determined by measuring the ingestion of neutrophils pre treated with the esterase inhibitors and washed; and b) 'phagocytosis-dependent' inhibition, which is due to the presence of the inhibitors during phagocytosis. With the cyclohexyl alkylphosphonofluoridates, phagocytosis-dependent inhibition was always greater than cell-dependent inhibition. Cell-dependent inhibition was irreversible and dependent on the duration of the incubation of neutrophils with inhibitor. Both types of inhibition were dependent on the concentration of the inhibitor. Poorly or non-phosphorylating analogues of the cyclohexyl alkylphosphonofluoridates of DFP were not inhibitory; nor did fluoride, the hydrolysis product of these inhibitors, inhibit ingestion under either condition. In addition, neither method of treating the neutrophils resulted in a decrease in neutrophil viability. Furthermore, pretreating the EAC1423 with the inhibitors did not decrease ingestion. We conclude that cell-dependent inhibition is due to the inactivation of an esterase required for phagocytosis which is in or on the neutrophil in an active form, and thus is susceptible to inhibition by the esterase inactivators before contact of the neutrophil with the phagocytic stimulus. Phagocytosis-dependent inhibition is interpreted as being due to inactivation of an esterase required for phagocytosis which is normally in an inactive precursor proesterase form that is activated by the interaction of the neutrophil with the phagocytic stimulus. The distinctly different inhibition profiles of the active and activatable esterases indicate that they are two different activities.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850067

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Membrane endopeptidases of human neutrophil.

Authors:  M F Tsan; M S Jiang
Journal:  Inflammation       Date:  1985-06       Impact factor: 4.092

2.  Requirement for cell-bound proteases in the mechanism of human neutrophil activation with various stimuli.

Authors:  R J Smith; S C Speziale; L M Sam; J M Justen; B J Bowman
Journal:  Inflammation       Date:  1986-09       Impact factor: 4.092

3.  Biochemical differences in the mechanism of macrophage lysosomal exocytosis initiated by zymosan particles and weak bases.

Authors:  D W Riches; J L Watkins; D R Stanworth
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

4.  Stimulation of polymorphonuclear leukocyte bactericidal activity by supernatants of activated human mononuclear cells.

Authors:  A S Cross; G H Lowell
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

5.  Chronologic changes of activities of naphthol AS-D acetate esterase and other nonspecific esterases in the mononuclear phagocytes of tuberculous lesions.

Authors:  T Tsuda; M Ando; K Shima; M Sugimoto; O Onizuka; H Tokuomi
Journal:  Am J Pathol       Date:  1979-11       Impact factor: 4.307

6.  Effects of a phagocytosis-stimulating factor on the phagocytic process of polymorphonuclear neutrophils.

Authors:  Y Ishibashi; T Yamashita
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

7.  Mechanisms of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro.

Authors:  R D Daimond; R Krzesicki
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

8.  Organophosphorus inhibition of lysosomal enzyme secretion from polymorphonuclear leucocytes. Evidence of a lack of a requirement for esterase activation.

Authors:  E L Becker; E P Koza; M Sigman
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

9.  Evidence that proteases are involved in superoxide production by human polymorphonuclear leukocytes and monocytes.

Authors:  S Kitagawa; F Takaku; S Sakamoto
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

10.  Antibody-dependent tumour cytolysis by human neutrophils: effect of synthetic serine esterase inhibitors and substrates.

Authors:  F Dallegri; G Frumento; A Ballestrero; R Goretti; A Torresin; F Patrone
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.